Table: begin end state 1 17 cytoplasmic 18 36 transmembrane 37 56 non-cytoplasmic 57 77 transmembrane 78 94 cytoplasmic 95 115 transmembrane 116 149 non-cytoplasmic 150 172 transmembrane 173 192 cytoplasmic 193 220 transmembrane 221 238 non-cytoplasmic 239 260 transmembrane 261 271 cytoplasmic 272 298 transmembrane 299 324 non-cytoplasmic 325 348 transmembrane 349 358 cytoplasmic 359 385 transmembrane 386 404 non-cytoplasmic 405 433 transmembrane 434 452 cytoplasmic 453 472 transmembrane 473 482 non-cytoplasmic 483 504 transmembrane 505 519 cytoplasmic
Input: >3607157 FitnessBrowser__Dino:3607157 MSDTTRTPGLAPKGADKALFAVTGGFIALFCAYALFDIEGLSALVDTSFAFSAKYFGLYW QVLLLATFLIGLVLCFLPGSRTLMGGLSTPEFGTFSWAAMIMCTLLAGGGVFWAAGEPIA HFLSTPPVFGDLSGDVQAQAHAALAQSFLHWGFLAWAILGSLTTVMLMHYHYDKGLPLAP RTLLYPLLGDRALSGPIGLIADASCIIAVVAGTVGPIGFLGLQMSYGLNDLTGIPDTFAT QAIAILALVGLYTVSAITGLAKGIKILSQINVLLAVVLLIFMLVAGPTMNIFAGFFGGMQ VYATHFFDMAMYRGDAGLFGDAGWLGWWTVFFWGWFMGYGPLMAVFIARISRGRSIRQII ITLSIAAPLITNFWFTIIGGSGIFFEIAEPGVVSGPFEGFNLPAGLLAITQAMPMGLILS VLFLVLTMCFVATTSDSMSYVISSTMTDGEPSTAMRAFWGLAMGVMALILISTGEGGIGK LQSFIVVTAVPVSLILLPSLWDALRITWMLGRTPEAKHA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server